IBM and Boehringer Ingelheim Partner on Generative AI for Tr

Generative AI partnership between IBM and Boehringer Ingelheim to revolutionize the discovery & development of antibody-based therapeutics

Related Keywords

Alessandro Curioni , Boehringer Ingelheim , Ibm , Should Know , Antibody Discovery , Vice President Accelerated Discovery ,